Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Research and development	$ 51,785	$ 34,627
General and administrative	17,076	16,569
Total operating expenses	68,861	51,196
Loss from operations	(68,861)	(51,196)
Interest income	5,199	701
Change in fair value of earnout liability	18	5,725
Change in fair value of common stock warrant liability	(575)	7,200
Other income (expense), net	(246)	(115)
Total other income, net	4,396	13,511
Net loss and comprehensive loss	$ (64,465)	$ (37,685)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (6.18)	$ (10.33)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	10,439,034	3,648,140